Takeda Pharmaceutical Co Ltd

Common Name
Takeda Pharmaceutical
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
47,455
Ticker
4502
Exchange
TOKYO STOCK EXCHANGE
Description
Takeda Pharmaceutical Co., Ltd. is a leading global biopharmaceutical company headquartered in Japan. Its primary purpose is to discover, develop, and deliver innovative medicines that improve patient...

Takeda Pharmaceutical's Climate Target Data Preview

As of 2024, Takeda Pharmaceutical has disclosed 3 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 3 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Takeda Pharmaceutical ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2025
Absolute-based Target
Scope 3 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2030
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2030

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Takeda Pharmaceutical's Greenhouse Gas Emissions Pathways

As of 2024, Takeda Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.

Does Takeda Pharmaceutical have a target to reduce the emissions from its operations?

As of 2024, Takeda Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.

Takeda Pharmaceutical's most ambitious operational target is to reduce these emissions by 40% by 2025, compared to a baseline of 690,166 Metric Tonnes of CO2 equivalent (mtCO2e) in 2016.

Takeda Pharmaceutical has already surpassed its operational emissions reduction target, with 2023 levels falling below the 2025 value, achieving its climate goal ahead of schedule.

Takeda Pharmaceutical's Operational (Scope 1+2) Emissions Pathway

2016202320250200 k400 k600 k800 kBaselineCurrent (-53%)Target 2025 (-40%)
Want Full Access to Takeda Pharmaceutical's Climate Targets Dataset?
Sign Up